Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3406]
News [7771]
Articles [63]
Editorials [9]
Conferences [207]
elearning [49]
CAPTEM vs FOLFIRI as second-line treatment for mCRC patients
Dr Filippo Pietrantonio - ‎IRCCS Istituto Nazionale dei Tumori Foundation...
CAPTEM vs FOLFIRI as second-line treatment for mCRC patients ( Dr Filippo Pietrantonio - ‎IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy )
15 Jul 2019
TRIBE2: Latest data for patients with mCRC
Dr Chiara Cremolini - Università di Pisa, Pisa, Italy
TRIBE2: Latest data for patients with mCRC ( Dr Chiara Cremolini - Università di Pisa, Pisa, Italy )
15 Jul 2019
Entrectinib in NTRK-fusion positive gastrointestinal cancers
Prof Salvatore Siena - Università degli Studi di Milano Statale, Milan, Italy
Entrectinib in NTRK-fusion positive gastrointestinal cancers ( Prof Salvatore Siena - Università degli Studi di Milano Statale, Milan, Italy )
15 Jul 2019
Latest results from KEYNOTE-181: Pembrolizumab versus chemotherapy as a second...
Prof Jean-Philippe Metges - Centre Hospitalier Régional et Universitaire de...
Latest results from KEYNOTE-181: Pembrolizumab versus chemotherapy as a second-line therapy for advanced oesophageal cancer ( Prof Jean-Philippe Metges - Centre Hospitalier Régional et Universitaire de Brest, Brest, France )
15 Jul 2019
Cancer care in Latin America
Dr Jean Rene Clemenceau
Cancer care in Latin America ( Dr Jean Rene Clemenceau )
12 Jul 2019
Tackling the increase in cancer cases worldwide
Prof Tezer Kutluk, Dr Eduardo Cazap
Tackling the increase in cancer cases worldwide ( Prof Tezer Kutluk, Dr Eduardo Cazap )
12 Jul 2019
Prof Ahmed Elzawawy on global cancer control
Dr Eduardo Cazap and Prof Ahmed Elzawawy
Prof Ahmed Elzawawy on global cancer control ( Dr Eduardo Cazap and Prof Ahmed Elzawawy )
12 Jul 2019
Latest advances in pancreatic cancer treatment and impact on practice
Prof Eric Van Cutsem and Dr Talia Golan
Latest advances in pancreatic cancer treatment and impact on practice ( Prof Eric Van Cutsem and Dr Talia Golan )
10 Jul 2019
Efficient in vitro screening for drug combinations: The TEVA model
Dr Angel Porgador - Ben-Gurion University of the Negev, Beersheeba, Israel
Efficient in vitro screening for drug combinations: The TEVA model ( Dr Angel Porgador - Ben-Gurion University of the Negev, Beersheeba, Israel )
10 Jul 2019
RET inhibition in RET aberrant cancers
Dr Vivek Subbiah - University of Texas MD Anderson Cancer Center, Houston, USA
RET inhibition in RET aberrant cancers ( Dr Vivek Subbiah - University of Texas MD Anderson Cancer Center, Houston, USA )
10 Jul 2019
A precision medicine approach to therapeutic resistance using KEAP1 somatic...
Dr Gerald Batist - McGill University - Segal Cancer Centre, Montreal, Canada
A precision medicine approach to therapeutic resistance using KEAP1 somatic mutations ( Dr Gerald Batist - McGill University - Segal Cancer Centre, Montreal, Canada )
10 Jul 2019
Direct targeting of STAT3 alone and in combination with immune checkpoint...
Dr David Tweardy - The University of Texas MD Anderson Cancer Center, Houston...
Direct targeting of STAT3 alone and in combination with immune checkpoint inhibitors to treat solid tumours ( Dr David Tweardy - The University of Texas MD Anderson Cancer Center, Houston, USA )
10 Jul 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation